Patents by Inventor Lionel Breton

Lionel Breton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins
    Patent number: 6572848
    Abstract: Agonists of chlorine/potassium channel receptor, for example taurine, gamma-aminobutyric acid (GABA), isoguvacin, isonipecotic acid, 4,5,6,7-tetrahydroisoxazolo-(5,4-c)pyrid-3(2H)-one, a benzodiazepine, steroids, and cromakalim, pinacidil, nicorandil and minoxidil, are well suited for treating sensitive human skin and are especially useful for treating/eliminating skin itching, pruritus, tautness, tingling and/or erythema.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: June 3, 2003
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Olivier De Lacharriere, Isabelle Nonotte
  • Desquamation/epidermal renewal of the skin and/or combating skin aging
    Patent number: 6562353
    Abstract: Cinnamic acid and derivatives thereof are well suited for promoting desquamation and/or stimulating epidermal renewal and/or combating intrinsic/extrinsic aging of the skin of a human subject in need of such treatment, by topically applying thereto, for such period of time as required to elicit the desired response, a cosmetically/therapeutically effective amount of cinnamic acid and/or of at least one derivative thereof.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: May 13, 2003
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Christel Liviero
  • Cosmetic or dermatological composition comprising an association between an elastase inhibitor compound of the N-acylaminoamide family and at least one anti-inflammatory compound
    Publication number: 20030072732
    Abstract: A cosmetic or dermatological composition characterized In that it comprises an association between an elastase inhibitor compound of the N-acylaminoamide family and at least one anti-inflammatory compound.
    Type: Application
    Filed: June 26, 2002
    Publication date: April 17, 2003
    Applicant: L'OREAL
    Inventors: Lionel Breton, Yann Mahe
  • 10-hydroxy-2-decenoic acid compounds for promoting desquamation/epidermal renewal of the skin and/or combating skin aging
    Patent number: 6544533
    Abstract: 10-Hydroxy-2-decenoic acid compounds, particularly the 10-hydroxydec-2-enoates, are well suited for promoting desquamation of human skin and/or stimulating epidermal renewal and thus combating intrinsic and/or extrinsic cutaneous aging.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: April 8, 2003
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Nathalie Pineau, Emile Benechie, Martine Li, Françoise Picot, Pierre Potier
  • Cosmetic or dermatological composition comprising a combination of an elastase inhibitor of the N-acylaminoamide family and at least one myorelaxing agent
    Publication number: 20030064085
    Abstract: Cosmetic or dermatological composition characterized in that it comprises a combination of an elastase inhibitor of the N-acylaminoamide family and at least one myorelaxing agent.
    Type: Application
    Filed: June 26, 2002
    Publication date: April 3, 2003
    Applicant: L'OREAL
    Inventor: Lionel Breton
  • Cosmetic or dermatological composition comprising an association between a compound of the N-acylaminoamide family and at least one matrix metalloproteinase inhibitor
    Publication number: 20030044438
    Abstract: A cosmetic or dermatological composition characterized in that it comprises an association between an elastase inhibitor compound of the N-acylaminoamide family and at least one metalloproteinase inhibiting compound.
    Type: Application
    Filed: June 26, 2002
    Publication date: March 6, 2003
    Applicant: L'OREAL
    Inventors: Lionel Breton, Yann Mahe
  • Cosmetic composition containing at least one auxin and its use
    Patent number: 6521239
    Abstract: The invention concerns the use of at least one auxin in a cosmetic composition as agent for stimulating the synthesis of skin lipids.
    Type: Grant
    Filed: October 10, 2000
    Date of Patent: February 18, 2003
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Florence Girerd, Beatrice Renault
  • Hydroxystilbene compounds for reducing/inhibiting protein glycation
    Patent number: 6521669
    Abstract: The hydroxystilbenes are well suited for reducing or inhibiting the glycation of certain substrates, for example the proteins of nails and/or hair, advantageously to preventatively and/or curatively combat glycation-related aging of the nails/hair.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: February 18, 2003
    Assignee: Societe L'Oreal S.A.
    Inventors: Christel Liviero, Lionel Breton, Hervé Pageon
  • Hydroxystilbene/ascorbic acid compositions for treating skin afflictions
    Publication number: 20030031693
    Abstract: Cosmetic/dermatological compositions, well suited, e.g., for skin-firming and anti-aging applications, as well as for stimulating the proliferation of dermal fibroblasts, comprise effective skin affliction-alleviating amounts of (a) at least one hydroxystilbene compound, in immixture with (b) at least one ascorbic acid compound, advantageously formulated into a topically applicable, physiologically/cosmetically acceptable vehicle, diluent or carrier therefor.
    Type: Application
    Filed: August 19, 2002
    Publication date: February 13, 2003
    Inventors: Lionel Breton, Christel Liviero
  • Composition containing at least one inhibitor of the enzyme 3-beta-HSD
    Publication number: 20030027772
    Abstract: The invention relates to a composition for topical application or oral administration, containing an effective quantity of at least one inhibitor of the enzyme 3&bgr;-hydroxysteroid dehydrogenase. This composition is designed in particular for the treatment of certain effects of chronological ageing and photo-ageing of the skin.
    Type: Application
    Filed: May 30, 2002
    Publication date: February 6, 2003
    Applicant: L'OREAL
    Inventor: Lionel Breton
  • Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discreet erythema
    Patent number: 6509014
    Abstract: Skin redness, rosacea and/or discreet erythema afflicting a mammalian, notably human patient, are therapeutically treated by administrating to such patient a therapeutically/cosmetically effective amount of at least one CGRP antagonist, advantageously in combinatory immixture with at least one antagonist of a neuropeptide other than CGRP, e.g., a substance P antagonist, and/or at least one inflammation mediator antagonist.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: January 21, 2003
    Assignee: Societe L'Oreal S.A.
    Inventors: Olivier De Lacharriere, Lionel Breton
  • Iridaceae extract and compositions containing it
    Patent number: 6471997
    Abstract: The subject of the present invention, in its most general aspect, is an extract of cells of at least one plant of the Iridaceae family, the said plant being obtained by in vitro culture. The subject of the invention is also compositions containing an extract of cells of at least one plant of the Iridaceae family, the use of the said extracts as antagonist of CGRP and/or of substance P and a process of cosmetic treatment involving one of the said compositions.
    Type: Grant
    Filed: September 9, 1996
    Date of Patent: October 29, 2002
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Richard Martin, Olivier De Lacharriere
  • Treating skin afflictions/conditions with 2-amino-4-alkylaminopyrimidine 3-oxide compounds
    Patent number: 6455054
    Abstract: Skin-soothing, -calmant and/or anti-inflammatory amounts of at least one 2-amino-4-alkylaminopyrimidine 3-oxide are well suited for therapeutically treating such afflictions/conditions of human skin as sensitive skin, skin discomfort, tautness, itchiness or swelling of the skin, blotchy red skin, or sensations of warming or burning of the skin.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: September 24, 2002
    Assignee: Societe l'Oreal S.A.
    Inventors: Yann Mahe, Jean-François Michelet, Lionel Breton
  • Hydroxystilbene/ascorbic acid compositions for treating skin afflictions
    Patent number: 6440433
    Abstract: Cosmetic/dermatological compositions, well suited, e.g., for skin-firming and anti-aging applications, as well as for stimulating the proliferation of dermal fibroblasts, comprise effective skin affliction-alleviating amounts of (a) at least one hydroxystilbene compound, in immixture with (b) at least one ascorbic acid compound, advantageously formulated into a topically applicable, physiologically/cosmetically acceptable vehicle, diluent or carrier therefor.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: August 27, 2002
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Christel Liviero
  • Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
    Patent number: 6416760
    Abstract: Topically applicable pharmaceutical/dermatological/cosmetic compositions well suited for the therapeutic treatment or care of sensitive human skin, hair, mucous membranes, nails and/or the scalp, in particular for reducing or avoiding the skin-irritant side effects of a variety of bioactive agents, for example the &agr;-hydroxy acids, comprise a therapeutically/cosmetically effective amount of at least one calcitonin gene related peptide (“CGRP”) antagonist, e.g., CGRP 8-37 or an anti-CGRP antibody.
    Type: Grant
    Filed: October 28, 1999
    Date of Patent: July 9, 2002
    Assignee: Societe L'Oreal
    Inventors: Lionel Breton, Olivier De Lacharriere
  • USE OF A SUBSTANCE P ANTAGONIST IN A PHARMACEUTICAL COMPOSITION
    Publication number: 20020068072
    Abstract: The invention relates to the use of a substance P antagonist for the preparation of a pharmaceutical composition, in particular for topical application, for treating lichens, prurigo, pruriginous toxicoderma and severe pruritus of neurogenic origin.
    Type: Application
    Filed: September 2, 1997
    Publication date: June 6, 2002
    Inventors: OLIVIER DE LACHARRIERE, LIONEL BRETON
  • Treating skin wrinkles/fine lines with calcium channel inhibitors
    Publication number: 20020058682
    Abstract: A regime or regimen for loosening/slackening and/or relaxing cutaneous and/or subcutaneous human skin tissue, advantageously for cosmetically/therapeutically treating skin wrinkles and fine lines, comprises administering to a candidate subject in need of such treatment, a thus-effective amount of at least one inhibitor of at least one calcium channel.
    Type: Application
    Filed: October 19, 2001
    Publication date: May 16, 2002
    Inventors: Lionel Breton, Isabelle Nonotte
  • Rosmarinus extracts for inhibiting/treating skin aging
    Publication number: 20020048594
    Abstract: The adverse/deleterious signs or effects of skin aging, for example, wrinkles and fine lines, withered skin, flabby skin, thinning of the dermis, etc., are inhibited/treated by topically applying onto the skin, hair and/or mucous membranes of an individual subject in need of such treatment, a thus effective amount of at least one extract of at least one plant of the Rosmarinus genus, or cosmetic/dermatological composition comprised thereof.
    Type: Application
    Filed: July 16, 2001
    Publication date: April 25, 2002
    Inventors: Lionel Breton, Francoise Bernerd, Richard Martin
  • Iridacea extracts for stimulating the immune system
    Publication number: 20020041908
    Abstract: A regime or regimen for stimulating the immune defenses of individuals in need of such treatment, notably the immune defenses of the skin, comprises administering to such individuals, for such period of time as required to elicit the desired response, a thus effective amount of at least one extract of at least one plant of the Iridacea genera, for example of the genus Romulea, Iris, Crocus, Gladiolus, Sisyrinchium or Hermodactylus.
    Type: Application
    Filed: July 18, 2001
    Publication date: April 11, 2002
    Inventors: Lionel Breton, Audrey Gueniche
  • Sophora japonica extracts for promoting desquamation/epidermal renewal of the skin and/or combating skin aging
    Publication number: 20020041907
    Abstract: A regime or regimen for promoting desquamation and/or for stimulating epidermal renewal and/or for combating intrinsic/extrinsic aging of the skin of individuals in need of such treatment, comprises administering to such individuals, whether orally, injectably or topically, for such period of time as required to elicit the desired response, a thus effective amount of at least one extract of at least one plant of the species Sophora japonica.
    Type: Application
    Filed: July 18, 2001
    Publication date: April 11, 2002
    Inventors: Christel Liviero, Pascale Pelletier, Lionel Breton